1Nguyen TA,Diodati JG,Pharand C.Resistance to clopidogrel:a review of the evidence[J].J Am Coll Cardiol,2005,45:1157-1164.
2Rocca B,Patrono C.Determinants of the interindividual variability in response to antiplatelet drugs[J].J Thromb Haemost,2005,3:1597-1602.
3Lev EI,Patel RT,Maresh KJ.Aspirin and clopidogrel drug response in patients undergoing percutaneous coronary intervention:the role of dual drug resistance[J].J Am Coll Cardiol,2006,47:27-33.
4Wenaweser P,Dorffler-Melly J,Imboden K.Stent thrombosis is associated with an impaired response to antiplatelet therapy[J].J Am Coll Cardiol,2005,45:1748-1752.
5Gurbel PA,Bliden KP,Hiatt BL.Clopidogrel for coronary stenting:response variability,drug resistance,and the effect of pretreatment platelet reactivity[J].Circulation,2003,107:2908-2913.
6Dziewierz A,Dudek D,Heba G.Inter-individual variability in response to clopidogrel in patients with coronary artery disease[J].Kardiol Pol,2005,62:108-117.
7Lau WC,Gurbel PA,Watkins PB.Contribution of hepatic cytochrome p450 3A4 metabolic activity to the phenomenon of clopidogrel resistance[J].Circulation,2004,109:166-171.
10Morel O,Ohlmann P,Jesel L.Variable extent of platelet responsiveness to clopidogrel inhibition:"clopidogrel resistance"[J].Ann Cardiol Angeiol,2005,54:194-200.
二级参考文献20
1Müller I, Besta F, Schulz C, et al. Effects of statins on platelet inhibition by a high loading dose of clopidogrel. Circulation, 2003, 108: 2195-2197.
2Gorchakova O, von Beckerath N, Gawaz M, et al. Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting. Eur Heart J, 2004, 25: 1898-1902.
3von Beckerath N, Gorchakova O, Motz A, et al. Full antiplatelet effect of a loading dose clopidogrel in the presence of statin therapy. Circulation, 2003, 108(suppl): IV-160.
4Serebruany VL, Malinin AI, Callahan KP, et al. Statins do not affect platelet inhibition with clopidogrel during coronary stenting. Atherosclerosis, 2001, 159: 239-241.
5Smith SM, Judge HM, Peters G, et al. Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention. Platelets, 2004, 15: 465-474.
6Saucedo JF, Aude W, Garza L. Statin therapy with atorvastatin or simvastatin does not decrease the antiplatelet effect of clopidogrel or eptifibatide during percutaneous intervention. Circulation, 2003, 108(suppl): 575-579.
7Serebruany VL, Midei MG, Malinin AI, et al. Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study. Arch Intern Med, 2004, 164: 2051-2057.
8Serebruany VL, Steinhubl SR, Hennekens CH. Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested. Circulation, 2003, 107: 1568-1569.
9Wienbergen H, Gitt AK, Schiele R, et al. Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. Am J Cardiol, 2003, 92: 285-288.
10Saw J, Steinhubl SR, Berger PB, et al. Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial. Circulation, 2003, 108: 921-924.
